The authorization raised immediate questions about who would get access to the antibody treatments, which are in short supply.
New York Times
By BY KATIE THOMAS AND NOAH WEILAND from NYT Health https://ift.tt/3pgF88r
November 9, 2020 at 04:03PM
The authorization raised immediate questions about who would get access to the antibody treatments, which are in short supply.
New York Times
By BY KATIE THOMAS AND NOAH WEILAND from NYT Health https://ift.tt/3pgF88r
November 9, 2020 at 04:03PM
No comments:
Post a Comment